These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31672256)

  • 1. Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck.
    Paterson C; Thomson MC; Caldwell B; Young R; McLean A; Porteous S; Clark S; Messow CM; Kean S; Grose D; Lamb C; Rizwannullah M; James A; Schipani S; Wilson C; Rulach R; Jones R
    Br J Oral Maxillofac Surg; 2019 Dec; 57(10):1119-1125. PubMed ID: 31672256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy-induced xerostomia, pre-clinical promise of LMS-611.
    Paterson C; Caldwell B; Porteous S; McLean A; Messow CM; Thomson M
    Support Care Cancer; 2016 Feb; 24(2):629-636. PubMed ID: 26143037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia.
    Haddad P; Karimi M
    Radiother Oncol; 2002 Jul; 64(1):29-32. PubMed ID: 12208571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
    LeVeque FG; Montgomery M; Potter D; Zimmer MB; Rieke JW; Steiger BW; Gallagher SC; Muscoplat CC
    J Clin Oncol; 1993 Jun; 11(6):1124-31. PubMed ID: 8501499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin/Troxerutine in patients with head and neck cancer].
    Grötz KA; Henneicke-von Zepelin HH; Kohnen R; al-Nawas B; Bockisch A; Kutzner J; Wüstenberg P; Naser-Hijazi B; Belz GG; Wagner W
    Strahlenther Onkol; 1999 Aug; 175(8):397-403; discussion 404. PubMed ID: 10481772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial.
    Garcia MK; Meng Z; Rosenthal DI; Shen Y; Chambers M; Yang P; Wei Q; Hu C; Wu C; Bei W; Prinsloo S; Chiang J; Lopez G; Cohen L
    JAMA Netw Open; 2019 Dec; 2(12):e1916910. PubMed ID: 31808921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial.
    Piboonratanakit P; Ferreira JN; Pravinvongvuthi K; Maison K; Urkasemsin G; Boonroung T; Prayongrat A; Lertbutsayanukul C; Sucharitakul J; Vacharaksa A
    BMC Oral Health; 2023 May; 23(1):288. PubMed ID: 37179287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer.
    Chung MK; Kim do H; Ahn YC; Choi JY; Kim EH; Son YI
    Otolaryngol Head Neck Surg; 2016 Sep; 155(3):423-30. PubMed ID: 27048670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
    Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
    Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
    N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind trial of amifostine versus placebo for radiation-induced xerostomia in patients with head and neck cancer.
    Lee MG; Freeman AR; Roos DE; Milner AD; Borg MF
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):142-150. PubMed ID: 30461207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
    Jakobsen KK; Carlander AF; Grønhøj C; Todsen T; Melchiors J; Paaske N; Madsen AKØ; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggard CD; von Buchwald C
    Trials; 2023 Sep; 24(1):567. PubMed ID: 37658468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.
    Sio TT; Blanchard MJ; Novotny PJ; Patel SH; Rwigema JM; Pederson LD; McGee LA; Gamez ME; Seeger GR; Martenson JA; Grover Y; Neben Wittich MA; Garces YI; Foote RL; Miller RC; Halyard MY
    Mayo Clin Proc; 2019 Sep; 94(9):1814-1824. PubMed ID: 31405750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
    Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia.
    Apperley O; Medlicott N; Rich A; Hanning S; Huckabee ML
    J Oral Rehabil; 2017 Nov; 44(11):889-895. PubMed ID: 28741683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.
    Warde P; O'Sullivan B; Aslanidis J; Kroll B; Lockwood G; Waldron J; Payne D; Bayley A; Ringash J; Kim J; Liu FF; Maxymiw W; Sprague S; Cummings BJ
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):9-13. PubMed ID: 12182969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-hyaluronate mouthwash on radiotherapy-induced xerostomia: a randomised clinical trial.
    Rupe C; Basco A; Gioco G; Patini R; Lucchese A; Micciché F; Massaccesi M; Lajolo C
    Support Care Cancer; 2023 Oct; 31(12):644. PubMed ID: 37851095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night.
    Beetz I; Schilstra C; Visink A; van der Schaaf A; Bijl HP; van der Laan BF; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2013 Nov; 109(2):311-6. PubMed ID: 23953752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.